News Sentiment

RAD sentiment intelligence

Radiopharm Theranostics Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 18 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.02 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

89/100 classification confidence.

Company focus 18

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-5.0% over one week, -5.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Radiopharm Theranostics (ASX:RAD) Jumps as Nuclear-Medicine Interest Builds

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 89/100 classification
One-week reaction -5.0% Price reacting lower
Trend fit Trend inactive -5.0% over four weeks
Fair value -52.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 15
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 18
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Investing News Network 5
Stock Titan 3
Kalkine 2
simplywall.st 2
Moomoo 1
Kalkine Media 1
Market source 1
smallcaps.com.au 1

Event Lens

What the news is about

Classified themes
Market update 15
Earnings 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-18 of 18